Profile
Anthony Barsotti is Senior Director at Deerfield Management Co. LP (Private Equity) since 2020.
Formerly, Dr. Barsotti was Director at Inzen Therapeutics, Inc. Education includes an undergraduate degree from the University of Pennsylvania conferred in 2005, and graduate and doctorate degrees from Columbia University Irving Medical Center conferred in 2008 and 2011, respectively.
Anthony Barsotti active positions
| Companies | Position | Start |
|---|---|---|
Deerfield Management Co. LP (Private Equity)
Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management invests in both private and public companies located in the United States. The firm targets companies operating in the fields of diagnostic, digital health, life science, medical device, and health care services. It provides financing for pre-seed, seed, early, later and growth stage capital requirements. | Director/Board Member | 01/01/2020 |
Former positions of Anthony Barsotti
| Companies | Position | End |
|---|---|---|
Inzen Therapeutics, Inc.
Inzen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops drugs for treatments of cancer, immune-inflammatory disorders, fibrotic, and degenerative diseases | Director/Board Member | - |
Training of Anthony Barsotti
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia University Medical Center
Columbia University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deerfield Management Co. LP (Private Equity)
Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management invests in both private and public companies located in the United States. The firm targets companies operating in the fields of diagnostic, digital health, life science, medical device, and health care services. It provides financing for pre-seed, seed, early, later and growth stage capital requirements. | Finance |
Inzen Therapeutics, Inc.
Inzen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops drugs for treatments of cancer, immune-inflammatory disorders, fibrotic, and degenerative diseases | Health Technology |
- Stock Market
- Insiders
- Anthony Barsotti
















